| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-119-20 | 25021-119 | HUMAN PRESCRIPTION DRUG | Cefuroxime sodium | Cefuroxime sodium | INJECTION, POWDER, FOR SOLUTION | INTRAVENOUS | 20160901 | N/A | ANDA | ANDA064125 | Sagent Pharmaceuticals | CEFUROXIME SODIUM | 1.5 g/16mL | 25 VIAL in 1 CARTON (25021-119-20) / 16 mL in 1 VIAL |
| 25021-118-10 | 25021-118 | HUMAN PRESCRIPTION DRUG | Cefuroxime sodium | Cefuroxime sodium | INJECTION, POWDER, FOR SOLUTION | INTRAMUSCULAR; INTRAVENOUS | 20160901 | N/A | ANDA | ANDA064125 | Sagent Pharmaceuticals | CEFUROXIME SODIUM | 750 mg/1 | 25 VIAL in 1 CARTON (25021-118-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |